EVMS receives more than $1 million in federal funds to develop a new approach to reverse Type 1 diabetes
March 25, 2010

New hope for diabetics: Innovative treatment begins clinical trials at MUHC
February 10, 2010

Nouvel espoir pour les diabétiques: début d'un essai clinique pour un traitement novateur au CUSM
February 10, 2010

Exsulin Corporation Announces Next Phase II Trial Of Novel Islet Regeneration Treatment In Type 1 Diabetes
September 11, 2009

EXSULIN CORPORATION ANNOUNCES PUBLICATION OF PHASE 2 TRIAL RESULTS FOR NOVEL ISLET REGENERATION TREATMENT IN TYPE 1 & TYPE 2 DIABETES
August 18, 2009